Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
23.86
-0.61 (-2.49%)
Jun 3, 2026, 4:00 PM EDT - Market closed
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $3 billion as of June 3, 2026. Its market cap has increased by 225.38% in one year.
Market Cap
3.00B
Enterprise Value
2.24B
1-Year Change
225.38%
Ranking
Category
Stock Price
$23.86
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $3.00B, an increase of 323.80%. That is a compound annual growth rate of 19.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 3.00B | 16.63% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 3.58B |
| Crinetics Pharmaceuticals | 3.44B |
| Relay Therapeutics | 3.42B |
| Viking Therapeutics | 3.40B |
| Oruka Therapeutics | 3.33B |
| Tango Therapeutics | 3.11B |
| Telix Pharmaceuticals | 3.08B |
| Denali Therapeutics | 3.07B |